UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Robertson Stephens Wealth Management LLC

Robertson Stephens Wealth Management LLC lessened its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 8.4% during the fourth quarter, HoldingsChannel.com reports. The firm owned 5,832 shares of the healthcare conglomerate’s stock after selling 532 shares during the period. Robertson Stephens Wealth Management LLC’s holdings in UnitedHealth Group were worth $3,070,000 as of its most recent SEC filing.

Other hedge funds have also bought and sold shares of the company. Wellington Management Group LLP increased its holdings in shares of UnitedHealth Group by 2.1% in the 3rd quarter. Wellington Management Group LLP now owns 25,220,234 shares of the healthcare conglomerate’s stock valued at $12,715,790,000 after acquiring an additional 527,526 shares during the last quarter. Northern Trust Corp raised its holdings in shares of UnitedHealth Group by 3.6% during the third quarter. Northern Trust Corp now owns 9,787,768 shares of the healthcare conglomerate’s stock worth $4,934,895,000 after purchasing an additional 341,749 shares during the period. Bank of New York Mellon Corp raised its stake in UnitedHealth Group by 2.2% during the third quarter. Bank of New York Mellon Corp now owns 8,242,282 shares of the healthcare conglomerate’s stock worth $4,155,676,000 after acquiring an additional 180,331 shares during the period. Charles Schwab Investment Management Inc. raised its position in shares of UnitedHealth Group by 0.5% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 5,843,207 shares of the healthcare conglomerate’s stock worth $2,937,976,000 after purchasing an additional 27,127 shares during the period. Finally, Sanders Capital LLC grew its stake in UnitedHealth Group by 6.5% during the 3rd quarter. Sanders Capital LLC now owns 5,757,410 shares of the healthcare conglomerate’s stock worth $2,902,829,000 after buying an additional 352,710 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the sale, the executive vice president now directly owns 9,364 shares in the company, valued at approximately $4,527,306.72. The sale was disclosed in a document filed with the SEC, which is accessible through this link. In other news, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares in the company, valued at $4,527,306.72. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the transaction, the chief accounting officer now directly owns 32,289 shares in the company, valued at $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on the stock. Piper Sandler upped their price target on shares of UnitedHealth Group from $566.00 to $571.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 17th. Oppenheimer reaffirmed an “outperform” rating and set a $610.00 price target on shares of UnitedHealth Group in a report on Wednesday, January 17th. Truist Financial restated a “buy” rating and issued a $600.00 target price on shares of UnitedHealth Group in a research report on Wednesday, April 17th. Deutsche Bank Aktiengesellschaft upped their price target on shares of UnitedHealth Group from $545.00 to $562.00 and gave the stock a “buy” rating in a research note on Friday, April 19th. Finally, Royal Bank of Canada cut their target price on shares of UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating for the company in a research note on Wednesday, April 17th. Four equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $570.05.

UnitedHealth Group Stock Performance

NYSE UNH traded up $5.25 on Thursday, hitting $489.36. 822,557 shares of the stock were exchanged, compared to its average volume of 4,400,709. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $554.70. The company has a market capitalization of $450.25 billion, a PE ratio of 29.98, a P/E/G ratio of 1.40 and a beta of 0.55. The business’s fifty day moving average is $483.69 and its 200 day moving average is $513.21. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.79.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. The firm had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The business’s revenue was up 8.6% compared to the same quarter last year. During the same quarter in the prior year, the business posted $6.26 EPS. Research analysts anticipate that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were paid a dividend of $1.88 per share. This represents a $7.52 annualized dividend and a dividend yield of 1.54%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s payout ratio is currently 45.97%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.